REG - Tristel PLC - Holding(s) in Company

TristelAnnouncement

10/09/2019 10:30

RNS Number : 8169L
Tristel PLC
10 September 2019
 


 
Tristel plc
("Tristel" or the "Company")
Holding(s) in Company
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that it was informed yesterday that Francisco Soler sold 2,565,000 ordinary shares of 1 penny each ("Ordinary Shares") on 9 September 2019.   Following this transaction, he now holds 3,147,834 Ordinary Shares, representing 7.06% of the Company's issued share capital. This holding includes family and related corporate vehicles as detailed below.
Following the sale, Francisco Soler has agreed not to sell any of his remaining equity interests in the Company for at least six months. Mr. Soler reserves the right to sell in this period if the share price of the Company should exceed 350p per share.
For further information please contact:       
 



Tristel plc


Tel: 01638 721 500




Paul Swinney, Chief Executive Officer








Liz Dixon, Finance Director


















Walbrook PR Ltd


Tel: 020 7933 8780 or tristel@walbrookpr.com




Paul McManus


Mob: 07980 541 893




Lianne Cawthorne


Mob: 07854 391 303














finnCap


Tel: 020 7220 0500




Geoff Nash / Giles Rolls, Corporate Finance








Alice Lane, ECM







 
TR-1: Standard form for notification of major holdings
 



NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i










1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:


Tristel plc




1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)




Non-UK issuer








2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights


x




An acquisition or disposal of financial instruments








An event changing the breakdown of voting rights








Other (please specify)iii:








3. Details of person subject to the notification obligationiv




Name


Francisco Soler




City and country of registered office (if applicable)








4. Full name of shareholder(s) (if different from 3.)v




Name


Windsor International Corporation
Hazelmount Trading Limited
Atlas World Carriers S.A.




City and country of registered office (if applicable)


Tortola, British Virgin Islands




5. Date on which the threshold was crossed or reachedvi:


09/09/19




6. Date on which issuer notified (DD/MM/YYYY):


09/09/19




7. Total positions of person(s) subject to the notification obligation








% of voting rights attached to shares (total of 8. A)


% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)


Total of both in % (8.A + 8.B)


Total number of voting rights of issuervii




Resulting situation on the date on which threshold was crossed or reached


7.06%










44,574,823




Position of previous notification (if
applicable)


12.82%
























 



8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii




A: Voting rights attached to shares




Class/type of

shares
ISIN code (if possible)


Number of voting rightsix


% of voting rights




Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)




GB00B07RVT99


3,147,834




























































SUBTOTAL 8. A


3,147,834


7.06%




 
 




B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Periodxi


Number of voting rights that may be acquired if the instrument is
exercised/converted.


% of voting rights














































































SUBTOTAL 8. B 1












 
 




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Period xi


Physical or cash
settlementxii


Number of voting rights


% of voting rights






























































































SUBTOTAL 8.B.2












 
 
 















 



9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii








Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)








Namexv


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold




Francisco A. Soler


100%






100%


















































































10. In case of proxy voting, please identify:




Name of the proxy holder








The number and % of voting rights held








The date until which the voting rights will be held














11. Additional informationxvi
















 



Place of completion


London, United Kingdom




Date of completion


09/09/2019



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLCKKDBCBKKNCD